In terms of Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Medicamen Biotech has informed that the Company has received request for issuance of duplicate share certificates in lieu of share certificates reported lost. The details of the share certificates reported lost are enclosed.
The above information is a part of company’s filings submitted to BSE.